| Autor: |
Ali S. Al-Ghamdi, Noah Alghanemy, Hanan Joharji, Dhafer Al-Qahtani, Hasan Alghamdi |
| Jazyk: |
angličtina |
| Rok vydání: |
2015 |
| Předmět: |
|
| Zdroj: |
Journal of Dermatology and Dermatologic Surgery, Vol 19, Iss 1, Pp 1-8 (2015) |
| Druh dokumentu: |
article |
| ISSN: |
2352-2410 |
| DOI: |
10.1016/j.jdds.2014.06.002 |
| Popis: |
Botulinum toxin (BT-A) is a neurotoxin which is produced by the Gram-positive anaerobic bacterium Clostridium botulinum. The efficacy of Botulinum toxin in treating hyperhidrosis and the glabellar lines is well known and FDA approved. Because BT-A inhibits the release of acetylcholine and many other neurotransmitters such as norepinephrine and substance P at the level of nerve ending, this toxin has been used to treat a lot of dermatological disorders which are thought to be triggered by these neurotransmitters. In this article we are discussing the medical off-label uses of BT-A in dermatology. |
| Databáze: |
Directory of Open Access Journals |
| Externí odkaz: |
|
